AbstractBackgroundEarly resuscitation after trauma-hemorrhagic shock (HS) with plasma rather than crystalloid may ameliorate systemic endothelial cell (EC) injury and dysfunction (endotheliopathy of trauma [EOT]). We postulated that endothelial lined microfluidic networks would be a useful platform to study the endothelial cell activation/injury under flow conditions to mimic HS. We then used the microfluidic system to further characterize the protective effects and optimal timing of plasma infusion on the development of “EOT” in our model.MethodsHuman umbilical vein endothelial cells (HUVEC) were added to microfluidic flow channels and after overnight perfusion the cells were subsequently treated with epinephrine (epi) and exposed to hypoxia reoxygenation (HR). Media alone or 5% human plasma was perfused either immediately following treatment (early plasma) or after a 3 hr. delay (late plasma). Glycocalyx injury was indexed by fluorescent microscopy and shedding of syndecan-1 and hyaluronic acid (HLA). Endothelial markers of activation/injury were also measured and included soluble thrombomodulin (sTM), tissue plasminogen activator (tPA), plasminogen activator inhibitor (PAI-1) and angiopoietin 1 and 2 (Ang-1 and 2). Sheddase activity was indexed by ADAM metallopeptidase domain 17 (ADAM-17).ResultsEndothelial cell and glycocalyx barrier function studied using microfluidic devices are a more realistic model of the glycocalyx endothelial vascular barrier than studies performed on endothelial cells using static (no flow) conditions. Conditions that mimic the internal mileau following hemorrhagic shock result in glycocalyx degradation and an inflammatory prothrombotic response by the endothelium. “Early” use of plasma in the microfluidic channel perfusate mitigated against these effects. Later perfusion with plasma had no protective effect.ConclusionA temporal effect to plasma administration was noted in our biomimetic model of the endothelial vascular barrier following shock. This suggests a protective role to “early” plasma administration in the severely injured patient. Background Early resuscitation after trauma-hemorrhagic shock (HS) with plasma rather than crystalloid may ameliorate systemic endothelial cell (EC) injury and dysfunction (endotheliopathy of trauma [EOT]). We postulated that endothelial lined microfluidic networks would be a useful platform to study the endothelial cell activation/injury under flow conditions to mimic HS. We then used the microfluidic system to further characterize the protective effects and optimal timing of plasma infusion on the development of “EOT” in our model. Methods Human umbilical vein endothelial cells (HUVEC) were added to microfluidic flow channels and after overnight perfusion the cells were subsequently treated with epinephrine (epi) and exposed to hypoxia reoxygenation (HR). Media alone or 5% human plasma was perfused either immediately following treatment (early plasma) or after a 3 hr. delay (late plasma). Glycocalyx injury was indexed by fluorescent microscopy and shedding of syndecan-1 and hyaluronic acid (HLA). Endothelial markers of activation/injury were also measured and included soluble thrombomodulin (sTM), tissue plasminogen activator (tPA), plasminogen activator inhibitor (PAI-1) and angiopoietin 1 and 2 (Ang-1 and 2). Sheddase activity was indexed by ADAM metallopeptidase domain 17 (ADAM-17). Results Endothelial cell and glycocalyx barrier function studied using microfluidic devices are a more realistic model of the glycocalyx endothelial vascular barrier than studies performed on endothelial cells using static (no flow) conditions. Conditions that mimic the internal mileau following hemorrhagic shock result in glycocalyx degradation and an inflammatory prothrombotic response by the endothelium. “Early” use of plasma in the microfluidic channel perfusate mitigated against these effects. Later perfusion with plasma had no protective effect. Conclusion A temporal effect to plasma administration was noted in our biomimetic model of the endothelial vascular barrier following shock. This suggests a protective role to “early” plasma administration in the severely injured patient. Correspondence: Lawrence N. Diebel MD, Michael and Marian Ilitch Department of Surgery, 6C University Health Center, 4201 Saint Antoine, Detroit, MI 48201, Phone: 313-577-5314, Fax: 313-577-5310, Email: ldiebel@med.wayne.edu Conflicts of interest to disclose: None This study was presented at the 75th annual meeting of the AAST, September 13-16, 2017, in Baltimore, MD. © 2017 Lippincott Williams & Wilkins, Inc.
from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2BUaWa9
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Neurosurgical contribution within a complex NF1 supraregional service Publication date: May 2019 Source: Clinical Neurology and Neurosurger...
-
Abstract Purpose To identify predictive factors for local control of locally advanced esophageal cancer by chemoradiotherapy, the relati...
-
Abstract Neurodegenerative diseases (NDs) are a group of chronic, progressive disorders characterized by the gradual loss of neurons that ...
-
Abstract Rheumatoid arthritis (RA) and psoriatic arthritis (PsA) are common in women of childbearing age and are often treated with terato...
-
Abstract The last 15 years have overwhelmed the surgical community with a range of approaches in treating pathologies involving the aortic...
-
Abstract In addition to its critical role in lysosomes for catabolism of sialoglycoconjugates, NEU1 is expressed at the plasma membrane an...
-
Abstract Background Gliomas with 1p/19q-codeletion as well as mutation of isocitrate dehydrogenase ( IDH ) 1 are typically characteriz...
-
Abstract Background Adenoid cystic carcinoma (ACC) is a salivary gland malignancy with poor long-term survival, which warrants studies a...
-
Abstract Background We evaluated our results of lengthening of free vascularized fibular grafts using a unilateral external fixator in p...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου